When was Pivot Bio founded?

Pivot Bio was founded in 2010 and became a unicorn in 2021, reaching the milestone in 11 years. It raised its 1st funding round 4 years after its incorporation.

Where is Pivot Bio located?

Pivot Bio is headquartered in Berkeley, United States. It is registered at Berkeley, California.

How many employees does Pivot Bio have?

As of Jul 31, 2026, the latest employee count at Pivot Bio is 303.

Is Pivot Bio a funded company?

Pivot Bio is a funded company, having raised a total of $618M across 7 funding rounds to date. The company's 1st funding round was a $750K Seed round, raised on Oct 30, 2014.

How much is Pivot Bio worth?

The latest valuation of Pivot Bio is $2B as of Sep 16, 2021.

When was the latest funding round of Pivot Bio?

Pivot Bio's latest funding was a $430M Series D round on Jul 19, 2021, with participation from 5 investors.

Is Pivot Bio a Crop Tech company?

The primary sectors of Pivot Bio are Crop Tech and Genomics.

Where does Pivot Bio rank among its competitors?

Pivot Bio ranks 19th amongst 1123 active competitors, of which 180 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Antheia, which secured $24M in Jan, 2026.

Who are the top competitors of Pivot Bio?

Pivot Bio's top competitors include Ginkgo Bioworks, Syngenta and Twist Bioscience. Among them, Antheia secured the most recent funding round in January, 2026.

Pivot Bio - 2026 Company Profile, Team, Funding & Competitors

Pivot Bio is a series D company based in Berkeley (United States), founded in 2010 by Alvin Tamsir and Karsten Temme. It operates as a Developer of microbial nitrogen products designed for crop nutrition enhancement. Pivot Bio has raised $618M in funding from investors like DCVC, Temasek and Monsanto, with a current valuation of $2B. The company has 1123 active competitors, including 180 funded and 78 that have exited. Its top competitors include companies like Ginkgo Bioworks, Syngenta and Twist Bioscience.

Sectors and market segments that Pivot Bio operate in

Pivot Bio serves in the Food and Agriculture Tech, Life Sciences market segments.The primary business model of Pivot Bio are:

Company Details

Developer of microbial nitrogen products designed for crop nutrition enhancement. These products deliver nitrogen directly to plant roots, optimizing nutrient uptake. The company’s technologies enhance crop production through timed nitrogen delivery. It offers programs rewarding farmers for improving nitrogen practices. The company provides solutions for corn, wheat, sorghum, and other small grains.

Website: pivotbio.com
Social
Email ID: *****@pivotbio.com
Phone Number: +1 **********, +1 **********
Registered Address: Berkeley, California

Key Metrics

Founded Year

2010

Location

Berkeley, United States

Stage

Series D

Total Funding

$618M in 7 rounds

Latest Funding Round

Series D, Jul 19, 2021, $430M

Post Money Valuation

$2B as on Sep 16, 2021

Investors

DCVC & 27 more

Ranked

19^th among 1123 active competitors

Employee Count

303 as on Jul 31, 2026

Similar Companies

Ginkgo Bioworks & 413 more

View Pivot Bio's full profile

Pivot Bio is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Pivot Bio, Inc CIN: 48.881.550/0001-93 , Brazil, Active	Dec 13, 2022	-	-	-
PIVOT BIO CIN: 273803526 , United States, Active	Dec 26, 999	-	332 (As on Dec 31, 2024)	-

Pivot Bio has raised a total funding of $618M over 7 rounds. Its first funding round was on Oct 30, 2014. Its latest funding round was a Series D round on Jul 19, 2021 for $430M. 5 investors participated in its latest round. Pivot Bio has 26 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Pivot Bio:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 19, 2021	$430M	Series D	$2B	-	DCVC, Temasek	Generation Investment Management, G2 Venture Partners, Rockefeller Capital Management
May 11, 2020	$100M	Series C	-	-	Temasek, Breakthrough Energy	DCVC, Prelude Ventures, Spruce Capital Partners, Bunge, Continental Grain Company, Codon Capital, Tekfen Ventures, Pavilion Capital Partners, Alan Cohen, Roger Underwood
Oct 02, 2018	$71.3M	Series B	-	-	Breakthrough Energy	Temasek

Access funding benchmarks and valuations. Sign up today!

View details of Pivot Bio's funding rounds and investors

The founders of Pivot Bio are Alvin Tamsir and Karsten Temme.

Here are the details of Pivot Bio's key team members:

Alvin Tamsir: Co-Founder & Chief Science Officer of Pivot Bio.
Contact Info: 1 email address
Karsten Temme: Co-Founder & Chief Innovation Officer of Pivot Bio.
Contact Info: 1 email address

View details of Pivot Bio's Founder profiles and Board Members

Pivot Bio's employee count trend

Pivot Bio has 303 employees as of Jul 26. Here is Pivot Bio's employee count trend over the years:

Uncover Pivot Bio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Pivot Bio include Ginkgo Bioworks, Syngenta and Twist Bioscience. Here is the list of Top 10 competitors of Pivot Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ginkgo Bioworks 2008, Boston (United States), Public	Autonomous labs for biotechnology, empowering scientists to design the living world	$796M	Viking Global Investors, T. Rowe Price & 53 others	81/100
2nd	Syngenta 2000, Basel (Switzerland), Acquired	Developer of technologies and sustainable farming practices for farmers	-	Analah Ventures, Europa	75/100
3rd	Twist Bioscience 2013, San Francisco (United States), Public	Developer of a semiconductor-based DNA synthesis platform	$321M	Foresite Capital, Fidelity Investments & 39 others	72/100
4th	Synthego 2012, Redwood City (United States), Acquired	Developer of CRISPR-engineered cell and gene therapies	$460M	8VC, Perceptive Advisors & 30 others	71/100
5th	Codexis 2002, Redwood City (United States), Public	Developer of high-performance enzymes for drug discovery	$111M	EDBI, Casdin Capital & 12 others	68/100
6th	AskBio 2001, Durham (United States), Acquired	Developer of AAV technologies for treating genetic and complex disorders	$235M	Vida Ventures, TPG & 4 others	68/100
7th	Amyris 2003, Emeryville (United States), Public	Developer of renewable products for industrial solutions	$487M	Temasek, Grupo Cornelio Brennand & 24 others	68/100
8th	Kula Bio 2018, Natick (United States), Series A	Manufacturer of microbial crop nutrition products	$86.7M	Collab Fund, Lowercarbon Capital & 16 others	68/100
9th	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	67/100
10th	Asimov 2017, Boston (United States), Series B	Provider of integrated suite for advanced genetic design and manufacturing	$234M	Andreessen Horowitz, Horizons Ventures & 11 others	65/100
19th	Pivot Bio 2010, Berkeley (United States), Series D	Developer of microbial nitrogen products designed for crop nutrition enhancement	$618M	Generation Investment Management, Temasek ... & 26 others	58/100